ARK持倉追蹤 | 減持頭部科技股
【Ark旗下基金持倉變化小結，2022年01月04日】
ARK系列主動型ETF當日共操作47筆，其中買入33只股4，賣出13只股票。
受騰訊減持影響，SEA(SE.N)隔夜大跌11%，ARKW乘機增持SEA逾9萬股，增持比例達35%；另有ARKF減持拼多多(PDD.O)25.5萬股，比例高達98.7%，幾近清倉。此外，ARKK還減持了推特(TWTR.N)逾206萬股，減持比例約爲20%。
Ark Invest的木頭姐發佈了年底的總結以及對未來的展望。Ark Invest作爲堅持創新領域投資的機構，其創立者木頭姐堅持創新型股票從長期看，現在已經處於深度價值的投資機會。
在疫情引起的“居家隔離”政策後，許多消費和工作行爲已經完全轉變，企業也更願意在科技領域加大投入。
今年通脹對市場的影響，破壞了對創新企業的估值；在波動性層面，算法交易做了很大貢獻；但是從其他市場如股權市場看，對通脹的預期並不明顯。
【ARK系列ETF介紹】
①ARKK：以顛覆性創新產業爲主要投資標的
ARKK專門投資革命性創新的公司，在5個美股ETF中，ARKK投資的公司類型最多元化，包括基因科技、全自動化、物聯網及金融科技相關的公司，可以說是其餘4個ETF的合體。
②ARKQ：以自動科技自動機器人技術爲主要投資標的
ARKQ投資的公司專注於機器人自動化相關的公司，當中投資自動駕駛的公司佔比最多，其次爲自動化機器人、3D打印、儲能技術、太空探索等的相關公司。
③ARKF ：以金融科技創新爲主要投資標的
ARKF主力投資金融科技相關公司，其中包括交易平臺、區塊鏈、衆籌平臺等等相關公司。
④ ARKW：以"下一代網絡"爲主要投資標的
ARKW專門投資"下一代網絡"的公司，當中佔比最多的公司爲雲計算、其次爲網絡安全、電子商務、大數據、人工智能等相關公司。
⑤ ARKG：以生物基因科技創新爲主要投資標的
ARKG這隻ETF主要專注於基因革命領域，包括基因編輯技術CRISPR、基因診斷治療、靶向治療、生物信息。
【uSMART目前支持部分美股10倍槓桿日內交易】
以上數據爲Cathie Wood個人/所在機構的過往操作，其交易背後之投資邏輯並不明確，不代表投資建議，注意風險。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app！
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
